Introduction {#Sec1}
============

Endothelial physiology is influenced by numerous biochemical factors. Hormones, paracrines, autocrines and other mediators define the permeability of the endothelial barrier, the anti-thrombotic nature of the endothelial cell surface and endothelium-dependent blood pressure regulation (reviewed in current special issue; and in Libby [@CR69]; Luscher [@CR71]; Landmesser and Drexler [@CR65]; Vierhapper et al. [@CR132]; Wojciak-Stothard and Ridley [@CR140]; Palmer et al. [@CR93]). Endothelial mechanobiology is a young field of research and little is known about mechanics-dependent signaling pathways. This is mainly due to the lack of proper techniques to quantify mechanics in living cells. Over the last decade, however, considerable progress has been made in various techniques, such as atomic force microscopy, laser tweezers, optical trap, pipette aspiration and microrheology. Experimental science is now equipped with a full tool kit facilitating the investigation of cellular mechanics and its physiological relevance (Lee and Lim [@CR67]; Van Vliet et al. [@CR131]). This review will highlight recent advances in the field of endothelial nanomechanics and its impact in endothelial physiology.

What is meant by "endothelial nanomechanics"? {#Sec2}
=============================================

Mechanobiology of the vascular system can be separated into cell mechanics and mechanical stimuli. On the one hand, external forces like fluid shear stress (FSS), vessel wall tension, vascular hydrostatic pressure and cell--cell contacts determine the mechanical stimuli in the cardiovascular system. These stresses affect endothelial function via mechanotransduction, i.e., activation of mechanosensitive pathways (Tzima [@CR128]; Ando and Yamamoto [@CR3]; Shyu [@CR115]; Johnson et al. [@CR44]). The corresponding mechanosensors exhibit various elements, including mechanosensitive ion channels, adhesion proteins, tyrosine kinase receptors, or caveolae (Liu et al. [@CR70]). Cell mechanics, on the other hand, describes the dynamics of cell (and tissue) elasticity, measured as mechanical stiffness and its impact on endothelial physiology. In more detail, nanomechanics focuses on the mechanical properties of single subcellular compartments (Roduit et al. [@CR107]; Gaboriaud and Dufrene [@CR26]; Kasas and Dietler [@CR46]). The four most prominent and mechanically distinct compartments in the endothelium are (1) the glycocalyx, (2) the cell cortex, (3) the cytoplasm and (4) the nucleus (Kasas et al. [@CR47]; Dahl et al. [@CR14]; Oberleithner et al. [@CR86], [@CR87]; Martins et al. [@CR73]; Weinbaum et al. [@CR135]). Recently, nanomechanics has come into the focus of research as it turned out that the stiffness of the single cellular compartments has a crucial impact on endothelial cell function. To understand the exact meaning of cell mechanics and its impact upon physiological mechanisms, it is important to define the molecular basis of the nanomechanical properties and to characterize their influence on cellular signaling processes.

Mechanics of glycocalyx in endothelial function {#Sec3}
===============================================

The endothelial glycocalyx (eGC) is a thick carbohydrate-rich layer, lining the luminal side of the endothelial surface that consists of proteoglycans and glycoproteins. The proteoglycans are decorated with long carbohydrate side chains, the glycosaminoglycans, among which heparan sulfate is the most prominent in the eGC. This mesh serves as a host for specific plasma proteins, soluble proteoglycans and hyaluronic acid. Together, they form a dynamic and complex interface between blood and tissue (Fig. [1](#Fig1){ref-type="fig"}). The total volume of the eGC in the human body is about 1.7 l and its thickness varies from a few hundreds of nanometers in capillaries to a few micrometers in arteries (van den Berg et al. [@CR129]; van Haaren et al. [@CR130]; Nieuwdorp et al. [@CR84], [@CR82]). Due to its high water content and the loose network, the eGC is several times softer than the underlying subcellular structures (Oberleithner et al. [@CR87]; Peters et al. [@CR97]).Fig. 1Cellular nanomechanics. Glycocalyx and cytoskeletal organization of endothelial cells determine the mechanical characteristics of the endothelium

One hallmark function of the eGC is the transmission of biochemical and biomechanical signals from the blood into endothelial cells. Changes in eGC nanomechanics can alter this function (=barrier function). Different processes are known that alter the nanomechanical properties of the eGC. As a polyanionic bio-gel, its volume and mechanics are regulated by the respective electrolyte concentration (Wolf and Gingell [@CR141]; Peters et al. [@CR97]). It has been shown that an extracellular sodium concentration in the upper physiological range leads to a compact eGC (=collapse; Oberleithner et al. [@CR87]). In contrast, treatment of endothelial cells with the polyphenol-rich compound WS1442 induces an increase in volume (=swelling) of the eGC (Peters et al. [@CR97]). The specific mechanisms of collapse and swelling depend on dominant interactions in the system (hydrogen bondings, ionic interactions, hydrophobic/hydrophilic properties, etc.) (Quesada-Perez et al. [@CR104]). Other processes, which modulate the nanomechanics of the eGC, are shedding and biosynthesis. Both can be induced by biochemical factors like hormones and enzymes (Reitsma et al. [@CR106]) or by FSS (Gouverneur et al. [@CR33]; Zeng and Tarbell [@CR142]). Enzymatic digestion of heparan sulfate as well as treatment of endothelial cells with thrombin, lipopolysaccharides, or tumor necrosis factor α compromises the structural integrity of the eGC leading to reduced eGC volume and stiffness (Peters et al. [@CR97]; Wiesinger et al. [@CR137]). In contrast, the biosynthesis of the eGC after enzymatic degradation leads to an increase in volume and a decrease in stiffness, as has been shown in vitro (Bai and Wang [@CR5]).

The eGC is the very first layer of the endothelium that comes into contact with blood. Thus, alterations of eGC nanomechanics lead to a change in the mechanical interaction between blood cells and the eGC constituents. Some theoretical models have been developed that describe such interactions (Weinbaum et al. [@CR136]; Han et al. [@CR35]; Pontrelli et al. [@CR100]). The eGC could serve as a mechanosensor. It is likely that a collapsed eGC can be less deformed by FSS and thereby becomes unable to transmit signals into the cell adequately, a condition that can promote cardiovascular disease. Additional to their function as FSS transmitters, the proteoglycan-associated heparin sulfate residues serve as attachment points for sodium ions and substances like albumin and other blood-borne proteins, hormones and enzymes (Siegel et al. [@CR116]; Reitsma et al. [@CR106]; Quinsey et al. [@CR105]; Kato [@CR49]; Li et al. [@CR68]; Ballinger et al. [@CR6]; Allen et al. [@CR1]; Wilsie and Orlando [@CR139]). Binding of these substrates modifies the nanomechanics of the eGC (Oberleithner et al. [@CR87]; Peters et al. [@CR97]; Job et al. [@CR43]). For instance, increased plasma sodium concentration leads to a stiffening of the glycocalyx and simultaneously increases cellular sodium uptake (Korte et al. [@CR59]; Peters et al. [@CR97]).

A soft and expanded eGC (Fig. [2a](#Fig2){ref-type="fig"}) is supposed to stand for a fully-functional endothelium, whereas a shedded or collapsed eGC most likely exerts adverse effects on the vascular system. Shedding, leading to a reduced eGC with compromised nanomechanics (Fig. [2b](#Fig2){ref-type="fig"}), facilitates edema formation (Salmon and Satchell [@CR108]; Strunden et al. [@CR121]; Becker et al. [@CR7]), cell vessel wall interactions (Constantinescu et al. [@CR12]; Henry and Duling [@CR37]; Mulivor and Lipowsky [@CR81]), loss of FSS perception (Thi et al. [@CR126]; Mochizuki et al. [@CR80]) and endothelial dysfunction (Nieuwdorp et al. [@CR83], [@CR84]; Drake-Holland and Noble [@CR18]). A collapsed (shrunk) eGC (Fig. [2c](#Fig2){ref-type="fig"}) has been discussed as being a promoter of vascular diseases (Peters et al. [@CR97]).Fig. 2eGC stiffness in endothelial function. **a** A well-hydrated eGC guarantees a functional endothelium. **b** Shedding damages the eGC, which results in decreased barrier function. **c** Acute collapse leads to similar functional changes as described in B but eGC nanomechanics are different

Cortical stiffness in endothelial function {#Sec4}
==========================================

Crossing the cell membrane, the first significant mechanical compartment inside the cell is, directly underneath the plasma membrane, the cell cortex. The biophysical properties of intracellular compartments are mainly determined by cytoskeletal components. Due to the three-dimensional cytoskeletal organization, the cell cortex as well as the cytoplasm and the nucleus, can be characterized by their distinct cytoskeleton-dependent nanomechanical properties (Oberleithner et al. [@CR86]; Kasas et al. [@CR47]; Dahl et al. [@CR14]; Martins et al. [@CR73]). Directly beneath the plasma membrane (50--200 nm), actin is organized in form of a dynamic network (Fig. [1](#Fig1){ref-type="fig"}) (Miranda et al. [@CR79]; Koning et al. [@CR58]). The cortical web, also known as peripheral actin, is made of cross-linked actin filaments (F-actin) that provide a supportive structure to the plasma membrane and its embedded proteins (Pollard and Cooper [@CR99]). The organization of the cortical cytoskeleton is highly dynamic as the actin filaments are regulated by a variety of actin binding proteins (dos Remedios et al. [@CR17]). The Arp2/3 complex, activated among others by cortactin, initiates filament formation. Additionally, actin polymerization is stimulated by Cdc42 and Rac1, both members of the Rho GTPase family. Cortactin and other proteins, such as filamin or fascin, stabilize the actin web by cross-linking filaments. Destabilization of the cortical actin network due to filament disassembly is induced by Cofilin, Gelsolin, or RhoA. Finally, motor proteins are able to cross-link actin filaments and simultaneously facilitate the force administration to the cortical web (dos Remedios et al. [@CR17]).

Cortical stiffness is mainly determined by the physiological status of the dynamic submembranous actin web. A high rate of actin polymerization and a dense filament organization go along with a relatively stiff cortex, whereas a depolymerization of F-actin results in cortical softening (Kasas et al. [@CR47]). Filamin A and/or α-actinin cross-link actin filaments and subsequently lead to an increased stiffness of the actin web (Esue et al. [@CR22]; Kasza et al. [@CR48]). Furthermore, motor proteins (e.g., non-muscle myosin II) contribute to cortical stiffness as they generate contractile forces within the filament network. By this, motor proteins induce a lateral tension within the cortical network leading to an inward directed tension (Paluch et al. [@CR94]; Schillers et al. [@CR110]; Stewart et al. [@CR120]; Trepat et al. [@CR127]; Mierke [@CR78]; Gorfinkiel and Blanchard [@CR32]).

There is evidence that nanomechanics of the cell cortex has significant influence on endothelial physiology (Hoffman and Crocker [@CR39]; Paluch et al. [@CR94]; Stewart et al. [@CR120]; Sokolov et al. [@CR118]). In particular, nitric oxide (NO) release and barrier function, both hallmarks of endothelial function, appear to be influenced by cortical nanomechanics.

In the vascular endothelium, a softening of the cell cortex induces NO synthesis and thereby is likely to facilitate vasodilation followed by an increase in tissue perfusion and decrease of blood pressure (Oberleithner et al. [@CR89], [@CR86]; Szczygiel et al. [@CR124]). Under certain physiological conditions, plasma potassium concentration can increase locally up to 12 mM, e.g., due to muscle or neuronal activity (Nordsborg et al. [@CR85]; Kofuji and Newman [@CR56]), which induces a rapid decrease in cortical stiffness (Oberleithner et al. [@CR86]). This softening of the cell cortex is driven by a membrane potential-dependent depolymerization of the submembranous actin web (Callies et al. [@CR11]). A decrease in cortical stiffness is generally caused by a destabilization of the cortical actin web, which verifies the physiological link of elasticity, actin organization and endothelial function (Fels et al. [@CR24]). Simultaneously, the activity of the endothelial NO synthase (eNOS) increases (Fig. [3a](#Fig3){ref-type="fig"}). Up to now, there are two mechanisms under discussion by which cortical softening induces eNOS activity. Firstly, it has been shown that eNOS activity is stimulated by an association with G-actin while it is inhibited by an association with F-actin (Kondrikov et al. [@CR57]). A decrease in cortical stiffness due to F-actin depolymerization may increase the association of eNOS with G-actin and therefore directly stimulates NO release (Fels et al. [@CR24]). Secondly, a soft cortex may render the cell more susceptible to shear stress. Mechanosensitive calcium channels in a "flexible" membrane are supposed to be readily activated by shear stress and subsequently increase intracellular calcium levels (Knudsen and Frangos [@CR55]; Kuchan and Frangos [@CR60]; Galan et al. [@CR27]). As eNOS is activated by the calcium-binding protein calmodulin, a soft cortex is likely to promote NO release. Since NO is a vasodilating gas, softening-induced eNOS activity will lead to increased tissue perfusion. Furthermore, blood pressure may decrease in case of systemic softening of the endothelial cortex.Fig. 3Cortical stiffness influences endothelial function. Softening of the cell cortex, induced by cortical actin depolymerization, decreases membrane abundance of ENaC and endothelial sodium uptake and increases eNOS activity and increases endothelial barrier function

Interestingly, these modulations of cortical stiffness and eNOS activity are independent of the bulk nanomechanics of the endothelial cells (Oberleithner et al. [@CR86]; Fels et al. [@CR24]). While, under physiological conditions, potassium concentrations may rise to a larger extent only locally, other mediators potentially act more systemically, i.e., on the whole vasculature. The mineralocorticoid hormone aldosterone, as well as the cytokine tumor necrosis factor alpha (TNFα), induce transient cortical softening associated with an increase in NO release (Fels et al. [@CR23]; Szczygiel et al. [@CR124]). Interestingly, sustained exposure to aldosterone or TNFα results in an opposite effect, described in detail in the subsequent section. In addition to the regulation of eNOS activity, other vascular mechanisms such as endothelial permeability are influenced by cortical nanomechanics.

Since the link between NO synthesis and cortical stiffness is the dynamic reorganization of the cortical actin cytoskeleton, it was hypothesized that the stiffness-dependent barrier function is again based on cortical actin dynamics.

This hypothesis is verified by the finding that exposure to sphingosine-1-phosphate increases peripheral (cortical) stiffness in pulmonary endothelial cells and thereby increases barrier function. The barrier-enhancing effect is most likely mediated via a signaling cascade including cortactin activation and subsequent actin filament formation in the cell cortex (Arce et al. [@CR4]). In contrast, thrombin acts as the counterpart in regulation of endothelial permeability as it decreases cortactin in the cortex and at the same time increases permeability (Arce et al. [@CR4]). Stimulation of myosin activity, as a second important determinant of cortical stiffness, leads to an increase in barrier function (Dudek et al. [@CR20]). These findings indicate that a decrease in cortical stiffness reduces endothelial barrier function. Hence, it may be concluded that a soft cell cortex indicates a physiological function of the endothelium.

In analogy to cortical softening, increased polymerization of cortical actin and concomitant stiffening of the endothelial cell cortex has (patho-)physiological consequences in the control of endothelial permeability and the response to hormone action (Hall [@CR34]; Birukova et al. [@CR8]). Endothelial stiffening by the C-reactive protein and the cathelicidin LL-37 peptide is found to have anti-inflammatory effects, possibly due to a decrease in endothelial permeability (Kusche-Vihrog et al. [@CR63]; Byfield et al. [@CR10]). These effects contribute to maintaining tissue fluid homeostasis and hence counteract the increased NO production and subsequent drop in blood pressure often accompanying acute inflammatory processes and septic shock. Endothelial cortical stiffening indeed controls endothelial NO release (Fig. [3b](#Fig3){ref-type="fig"}), as a cell with a stiff cortex produces reduced amounts of NO (Oberleithner et al. [@CR89], [@CR86]; Kidoaki and Matsuda [@CR53]; Fels et al. [@CR23]). The phenomenon "increased endothelial cortical stiffness/reduced NO release" was recently termed "stiff endothelial cell syndrome (SECS)" (Lang [@CR66]). Diminished NO release and thus a shift of endothelial action towards increased vasoconstriction, is also the hallmark of endothelial dysfunction, a clinical predictor for expecting cardiovascular diseases later in life (Endemann and Schiffrin [@CR21]; Schachinger et al. [@CR109]). One of the crucial prerequisites leading to an increase in endothelial stiffness and a reduced NO production is a rather high plasma aldosterone level, a major risk factor for vasculopathies. Upon prolonged treatment (\>20 min) with aldosterone, endothelial cells swell (Oberleithner et al. [@CR90]; Schneider et al. [@CR111]) and stiffen (Oberleithner et al. [@CR88]). Both of these effects are blocked either by the specific epithelial sodium channel (ENaC) blocker amiloride or by the aldosterone antagonist spironolactone. Both prevent a (further) augmentation in endothelial stiffness upon raising extracellular sodium concentrations from 135 to 145 mM in the presence of aldosterone (Oberleithner et al. [@CR89]). Incidentally, these two factors, aldosterone and high sodium, also cause an increase in ENaC surface expression (Kusche-Vihrog et al. [@CR62]; Korte et al. [@CR59]), indicating a key role of aldosterone in controlling ENaC activity by increasing the channel's abundance at the endothelial cell surface (Alvarez et al. [@CR2]; Snyder [@CR117]). ENaC is widely abundant in various tissues throughout the human body, including epithelia tissues where this sodium channel mediates the rate-limiting step of sodium transport (Garty and Palmer [@CR29]; Golestaneh et al. [@CR31]). In vascular endothelium, ENaC is different, as the major portion of sodium exits the blood capillary system through a more or less "leaky" paracellular pathway (Mehta and Malik [@CR76]). Also, the ENaC expression level is clearly lower as compared to epithelial tissues (Kusche-Vihrog et al. [@CR61]). Recently, a direct link between ENaC expression and NO release has been established, suggesting the functional role of ENaC in the vascular endothelium (Jeggle et al. [@CR42]). Cells with elevated ENaC expression exhibit an increase in mechanical cortical stiffness in vitro and ex vivo. Taken together, ENaC determines cortical endothelial stiffness and plays a major role in endothelial (dys)function contributing to the control of vascular tone. The mechanistic basis of the link between ENaC and endothelial stiffness most likely relies on the direct interaction of ENaC with F-actin located in the subapical pool underneath the plasma membrane (Mazzochi et al. [@CR74], [@CR75]). Alterations in cortex formation upon changes in the ENaC surface expression could thus also be ascribed to this interaction, as it might increase actin polymerization in this compartment and hence increase cortical stiffness. The sequence of events, whether ENaC membrane insertion promotes actin polymerization or vice versa, has not yet been elucidated.

In addition to chemical mediators, mechanical stimuli affect actin organization (most likely influencing cortical stiffness) and endothelial function. An in vitro increase in hydrostatic pressure, mimicking blood pressure in vivo, induces actin reorganization and affects endothelial permeability (Shin et al. [@CR114]). Fluid shear stress influences actin reorganization (Seebach et al. [@CR113]) and alters the endothelial barrier (Tarbell [@CR125]; Katoh et al. [@CR50]; Ando and Yamamoto [@CR3]; Shyu [@CR115]; Johnson et al. [@CR44]). Finally, substrate stiffness was shown to induce actin polymerization, modulating barrier function in a dose-dependent manner; substrate stiffness simulating "physiological conditions" improves barrier function while stiffer and softer substrates disrupt barrier function (Birukova et al. [@CR9]).

Besides the direct link between cortical stiffness and endothelial function, the elasticity of the cell cortex can be seen as a parameter that determines endothelial physiology in a more general way. For instance, aging cells lose their elasticity due to an increased cytoskeletal organization (Sokolov et al. [@CR118]; Schulze et al. [@CR112]; Kelly et al. [@CR51]; Druppel et al. [@CR19]; Kliche et al. [@CR54]; Qiu et al. [@CR103]). Even basic processes that usually occur in cellular life, such as mitosis, differentiation and development, can be related to changes in cortical stiffness (Stewart et al. [@CR120]; Patel et al. [@CR95]; Kidoaki and Matsuda [@CR53]; Hoffman and Crocker [@CR39]).

One may now assume that a soft cortex is a "fountain of youth" and guarantees a reasonably low blood pressure and a healthy organism. This is, however, not the case. Apparently, the physiological impact of cortical stiffness on physiological mechanisms is highly tissue-specific. In contrast to the endothelium, a soft cortex can even indicate a pathophysiological state of a cell. In ventricular myocytes, for instance, the relationship between elasticity and NO release appears to be different. There, an inhibition of myosin by blebbistatin decreases cell stiffness and simultaneous inhibits NOS activity (Walsh and Cole [@CR133]; Dedkova et al. [@CR15]). Furthermore, it has been shown that the metastatic behavior of cancer cells directly correlates with the cell's elasticity. Cancer cells with a low elasticity (soft cells) are more likely to spread than stiffer ones (Ketene et al. [@CR52]). Additionally, breast cancer cells induce softening of the endothelium to ease extravasation, leading to facilitated metastasis formation (Mierke [@CR78]).

Cytoplasm mechanics in endothelial function {#Sec5}
===========================================

While single actin filaments are predominantly found in the cortex, actin stress fibers (bundles of 10--30 filaments) span the whole cytoplasm. These fibers determine cell morphology and stability. They also contribute to focal adhesions and thus are involved in the mechanisms of cell motility (Pellegrin and Mellor [@CR96]; Fletcher and Mullins [@CR25]; Prasain and Stevens [@CR102]). Additionally, the cytoplasm is pervaded by microtubules and intermediate filaments. Microtubules are tube-like polymerized protein (tubulin) filaments facilitating the transport of organelles and vesicles. They are also responsible for the maintenance of cell shape, preventing compression.

Both microtubules and intermediate filaments determine cytoplasmic (bulk) stiffness (Wang [@CR134]; Janmey et al. [@CR41]; Kasas et al. [@CR47]; Herrmann et al. [@CR38]) (Fig. [2](#Fig2){ref-type="fig"}).

The molecular nature of the contribution of tubulin to cell nanomechanics has been investigated in detail (Gardel et al. [@CR28]). So far, the microtubule network is supposed to represent a compressive load-bearing component that counteracts the tensile forces generated by the cortical actimyosin web (Ingber [@CR40]).

The physiological relevance in stiffness-dependent signaling pathways in endothelial cells is, however, still unclear. What is known so far is that microtubule-associated proteins (e.g., MAP65) directly influence the flexibility of single microtubules, most likely resulting in a change in cellular elasticity (Portran et al. [@CR101]). Furthermore, in the developing organ of Corti, the fibroblast growth factor induces a microtubule-dependent decrease in cell stiffness leading to hearing loss (Szarama et al. [@CR123]).

Intermediate filaments, of which vimentin is the dominant network-forming member in the endothelium, support the three-dimensional organization of the cell and its organelles (Kamei [@CR45]). Their mechanical properties as well as their contribution to cell mechanics have been reviewed by Herrmann et al. ([@CR38]). Intermediate filaments play a key role in mechanotransduction as mutation or deletion of several intermediate filament proteins leads to cell fragility, heart failure and muscle dystrophies. Even leucocyte diapedesis and endothelial nitric oxide release depend on proper intermediate filament formation (Herrmann et al. [@CR38]).

Although the role of intermediate filaments in (endothelial) physiology is well documented and the molecular contributions to cell mechanics are known, evidence for a direct link between intermediate filament-dependent mechanics and endothelial function is still missing. Data on intermediate filament and microtubule mechanics and its impact on endothelial physiology indicate that several different nanomechanical signaling pathways exist that await future investigation.

Nuclear stiffness in endothelial function {#Sec6}
=========================================

Each individual component of the cellular cytoskeleton described in the previous sections is directly linked to the cell nucleus. Plectin (nesprin-3) provides a link to the cytoplasmic network of intermediate filaments (Wilhelmsen et al. [@CR138]), whereas Nesprin-1/2 mediates binding to microtubules and the actin network (Padmakumar et al. [@CR92]; Zhang et al. [@CR143]). Nesprins connect cytoskeletal networks with the intranuclear lamin network via SUN 1/2 proteins (Haque et al. [@CR36]). It is therefore conceivable that all of the mechanical stimuli perceived by the cell through actin, microtubule, or intermediate filament networks are integrated on the level of the nuclear lamina.

Similar to the cortical mechanics, the nucleus of an eukaryotic cell could also be an important contributor to the overall mechanics of the cell. Nuclei of several cell types have been shown to be two- to ten-fold stiffer than the respective cytosol (Martins et al. [@CR73]; Ofek et al. [@CR91]). In mechanical terms, the cell nucleus could be envisioned as being a supramolecular shock absorber capable of withstanding considerable stress (Dahl et al. [@CR13]). A connection between cytoskeleton and the nuclear envelope further strengthens the notion of a direct involvement of the nucleus in mechanosensing and mechanotransduction (Maniotis et al. [@CR72]). Recently, the pioneering work from the laboratory of Dennis Discher demonstrated that the nucleus can serve as an intracellular "mechanostat" (Swift et al. [@CR122]), a structure that is able to sense and respond to changes in the mechanical properties of the cellular environment by changing its own stiffness (Fig. [4a](#Fig4){ref-type="fig"}).Fig. 4Nuclear elasticity in endothelial function. Elasticity of the cell nucleus regulates gene expression and endothelial function

In the light of recent advances in the field of "nuclear mechanics", it is tempting to speculate that nuclei of endothelial cells could be directly involved in mediating physiological functions in response to mechanical stimuli. Nuclei of endothelial cells are particularly large in comparison to those of other cell types. Nuclei bulge into the lumina of blood vessels, thus being directly exposed to the shear strain exerted by the blood flow. Consequently, any change in nuclear volume and/or stiffness could have a strong influence on blood flow, in particular in vessels of small inner diameters. According to Hagen-Poisseulle's law, the flow resistance is related to the 4th potency of the vessel diameter. Thus, a small change in nuclear volume, as shown and quantified in vascular endothelium in response to aldosterone (Oberleithner et al. [@CR90]), could have a considerable impact in arterioles and capillaries. Bulging nuclei could be a significant hindrance for blood flow, in particular when the nuclei stiffen at the same time.

There is evidence that endothelial cell nuclei respond to mechanical stimuli. Nuclei flatten when exposed to physiological shear stress (Deguchi et al. [@CR16]). In addition, nuclei of the cells exposed to shear stress stiffen (Fig. [4b](#Fig4){ref-type="fig"}). Apparently, flattening and stiffening of the nuclei could be the consequence of a shape change induced by shear forces. However, the "recovery in shape" and, at the same time, the maintenance of nuclear stiffness upon release of the shear forces, point towards a more complex nuclear remodeling mechanism. The question, whether the expression of the lamin A network at the nucleoplasmic side---a major determinant in the control of the nuclear envelope plasticity (Lammerding et al. [@CR64])---is responsible for the nuclear 'mechanostat' function, remains open (Swift et al. [@CR122]).

There is another reason indicating a potential role of lamin A in the regulation of nuclear plasticity. A mutation of lamin A, which results in an irreversible (permanent) anchoring of the mutated product in the nuclear envelope, results in a severe clinical manifestation termed Hutchison-Gilford progeria syndrome (HGPS) (Merideth et al. [@CR77]). Affected individuals undergo drastically accelerated aging and die in their teens of cardiovascular-related diseases such as stroke or myocardial infarction (Gerhard-Herman et al. [@CR30]). At tissue level, major arteries of HGPS patients demonstrate a severe degeneration of the smooth muscle cell layer (Stehbens et al. [@CR119]). The role of endothelial cells in the development of the syndrome has not been fully assessed to date. However, at the level of individual cell nuclei, the presence of a mutated rigid lamin A network at the inner side of the nuclear envelope has been linked to significant stiffening of such nuclei (Philip and Dahl [@CR98]). It is therefore tempting to speculate that "stiff nuclei" cause an overall stiffening of the endothelial cell. This could result in a severe form of the stiff endothelial cell syndrome (Lang [@CR66]). In this case, the ability of the endothelial cell of sensing and responding to mechanical stimuli might be disrupted. As a result, the downstream signaling directed towards vascular smooth muscle is expected to be impaired, possibly explaining the degradation of vascular smooth muscle cell layer in HGPS.

In summary, the question, whether nuclear mechanics follows mechanical alterations evoked from the exterior environment as postulated by the "nuclear mechanostat" theory (Swift et al. [@CR122]) and/or whether any changes in nuclear elasticity could primarily alter endothelial function, will be an exciting area of cell research in the near future.

Conclusion and perspectives {#Sec7}
===========================

In conclusion, the elastic properties of the four compartments, (1) glycocalyx, (2) cortex, (3) cytoplasm and (4) nucleus, are mainly determined by the composition of the respective structural elements. The dynamic interactions between those elements with cross-linker and motor proteins determine the mechanical properties of the respective region. Endothelial nanomechanics has a distinct influence on endothelial function. Various molecular mechanisms control the mechanical properties of living cells. In turn, cellular mechanics control intracellular signaling cascades. Thus, chemical and mechanical signaling pathways are strongly linked to each other. Nanomechanics provides information on the physiological state of the endothelial cell in terms of nitric oxide release and barrier function. A soft cell cortex, combined with a soft, well-hydrated glycocalyx, increases NO formation, which is a prerequisite for a functionally intact vasculature. Any changes in elasticity at the level of the eGC glycocalyx, the cell cortex and the cell nucleus, can have a significant influence on endothelial function in terms of local blood flow, tissue perfusion and, finally, arterial blood pressure.
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